These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 2545224)
1. Human monoclonal antibodies to influenza virus: IgG subclass and light chain distribution. Frank AL; Six HR; Marchini A Viral Immunol; 1989; 2(1):31-6. PubMed ID: 2545224 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the subclasses and light chain types of IgG antibodies to rubella. Skvaril F; Schilt U Clin Exp Immunol; 1984 Mar; 55(3):671-6. PubMed ID: 6423327 [TBL] [Abstract][Full Text] [Related]
4. Subclass distribution of IgG and IgA responses to rubella virus in man. Stokes A; Mims CA; Grahame R J Med Microbiol; 1986 Jun; 21(4):283-5. PubMed ID: 3723581 [TBL] [Abstract][Full Text] [Related]
5. Production of human monoclonal antibody to X31 influenza virus nucleoprotein. Crawford DH; Callard RE; Muggeridge MI; Mitchell DM; Zanders ED; Beverley PC J Gen Virol; 1983 Mar; 64 Pt 3():697-700. PubMed ID: 6298350 [TBL] [Abstract][Full Text] [Related]
6. The human and murine influenza-specific B cell repertoires share a common idiotope. Sigal NH; Chan M; Reale MA; Moran T; Beilin Y; Schulman JL; Bona C J Immunol; 1987 Sep; 139(6):1985-90. PubMed ID: 3114381 [TBL] [Abstract][Full Text] [Related]
7. Isotypic distribution of human anti-thyroglobulin IgG antibodies: methodological difficulties. Barra A; Aucouturier P; Preud'homme JL Diagn Immunol; 1986; 4(5):228-32. PubMed ID: 3791841 [TBL] [Abstract][Full Text] [Related]
8. [Preparation and characterization of monoclonal antibodies against M2 protein of avian influenza virus]. Li YQ; Yang J; Zhang L; Wei L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):475-8. PubMed ID: 18466706 [TBL] [Abstract][Full Text] [Related]
9. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. He Q; Velumani S; Du Q; Lim CW; Ng FK; Donis R; Kwang J Clin Vaccine Immunol; 2007 May; 14(5):617-23. PubMed ID: 17344345 [TBL] [Abstract][Full Text] [Related]
10. Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells. Yarchoan R; Murphy BR; Strober W; Schneider HS; Nelson DL J Immunol; 1981 Dec; 127(6):2588-94. PubMed ID: 6975330 [TBL] [Abstract][Full Text] [Related]
11. Subclass characterization of IgG anti-S.typhi lipopolysaccharide antibodies with commercial monoclonal antibodies. Nardiello S; Digilio L; Leva E; Pizzella T; Galanti B Boll Ist Sieroter Milan; 1989; 68(3):234-40. PubMed ID: 2491431 [TBL] [Abstract][Full Text] [Related]
12. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells. Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863 [TBL] [Abstract][Full Text] [Related]
13. Antigen nature and complexity influence human antibody light chain usage and specificity. Smith K; Shah H; Muther JJ; Duke AL; Haley K; James JA Vaccine; 2016 May; 34(25):2813-20. PubMed ID: 27113164 [TBL] [Abstract][Full Text] [Related]
14. Construction of human monoclonal antibodies against rabies NS-protein antigen by Epstein-Barr virus transformation. Gebauer W; Lindl T Arzneimittelforschung; 1990 Jun; 40(6):718-22. PubMed ID: 2168706 [TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies. Hocart MJ; Mackenzie JS; Stewart GA J Gen Virol; 1989 Sep; 70 ( Pt 9)():2439-48. PubMed ID: 2778440 [TBL] [Abstract][Full Text] [Related]
16. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities. Gupta CK; Leszczynski J; Gupta RK; Siber GR Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058 [TBL] [Abstract][Full Text] [Related]
17. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. El-Madhun AS; Cox RJ; Haaheim LR J Infect Dis; 1999 Oct; 180(4):1356-60. PubMed ID: 10479172 [TBL] [Abstract][Full Text] [Related]
18. The use of human antigen-specific monoclonal antibodies in an enzyme-linked immunosorbent assay for the determination of anti-HBsAg antibody subclasses. Persson MA; Hammarström L; Smith CI; Stricker EA J Immunol Methods; 1987 Jun; 100(1-2):107-15. PubMed ID: 2439599 [TBL] [Abstract][Full Text] [Related]
19. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related]
20. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]